Park Ridge, NJ, United States of America

Marc Isaac Damelin

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Marc Isaac Damelin

Introduction

Marc Isaac Damelin is an accomplished inventor based in Park Ridge, New Jersey, with a notable portfolio of four patents. His work primarily focuses on the development of innovative therapies, particularly in the field of antibody-drug conjugates. Damelin's contributions to the biopharmaceutical industry have been significant, especially through his latest inventions which harness cutting-edge technology to advance medical treatments.

Latest Patents

Damelin's recent patents include two groundbreaking antibody-drug conjugates. The first, titled "Anti-EFNA4 antibody-drug conjugates," presents a method for preparing and utilizing these conjugates to target specific disease mechanisms. The second patent, "Anti-PTK7 antibody-drug conjugates," similarly outlines methods for developing these therapeutic agents, aimed at enhancing the efficacy of treatments against various conditions. Both patents underscore Damelin's commitment to harnessing the power of antibodies to improve patient outcomes through targeted therapies.

Career Highlights

Throughout his career, Damelin has made significant contributions while working with major companies in the pharmaceutical industry. He has held positions at Pfizer Corporation and AbbVie Stemcentrx LLC, where he collaborated with leading researchers and contributed to transformative projects in drug development. His experience in these esteemed organizations has undoubtedly shaped his innovative approach and expertise in the field.

Collaborations

In his journey as an inventor, Damelin has collaborated with notable colleagues, including Puja Sapra and Alexander John Bankovich. These partnerships have played a crucial role in enhancing the quality and scope of his research and developments. Working alongside talented peers has allowed Damelin to share knowledge and combine insights, ultimately leading to the creation of his impactful patents.

Conclusion

Marc Isaac Damelin stands out as a notable figure in the realm of biotechnology, marked by his inventive spirit and dedication to advancing medical therapies. Through his innovative patents and collaborations with industry leaders, he continues to pave the way for future breakthroughs in antibody-drug conjugates that have the potential to change lives. His contributions to the field serve as an inspiration for aspiring inventors and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…